Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 11:1-11.
doi: 10.1080/09540121.2024.2357811. Online ahead of print.

Prevalence and risk factors for post-COVID conditions of COVID-19 among persons with HIV in Washington, DC

Affiliations

Prevalence and risk factors for post-COVID conditions of COVID-19 among persons with HIV in Washington, DC

Shannon Barth et al. AIDS Care. .

Abstract

Post-COVID conditions (long COVID) are defined as COVID symptoms persisting 28 days post-initial infection. The limited research available on the prevalence and experiences of post-COVID conditions among persons with HIV (PWH) indicates potential increased risk for post-COVID conditions. The purpose of this study was to characterize prevalence, symptom clustering, impact, and potential risk factors of post-COVID conditions among PWH. Data come from the COVID-19 survey, conducted as a sub-study of the DC Cohort Longitudinal HIV Study, an ongoing study of over 12,000 PWH living in Washington, DC. Survey data were matched to electronic medical record data. Prevalence estimates and multivariable logistic regression analyses were calculated comparing those with and without post-COVID conditions. The prevalence of post-COVID conditions among PWH was 46% with no significant differences among demographic or HIV measures. Those with history of asthma were more likely to report post-COVID conditions symptoms. Among those with post-COVID conditions, 81% reported three or more initial COVID symptoms. Retired/disabled PWH were more likely to report post-COVID conditions compared to employed (aOR = 2.37, 95% CI = 1.06, 5.33). Post-COVID conditions significantly limited activities of daily living. Programs are needed to address the long-term impact of post-COVID conditions on activities of daily living among PWH.

Keywords: COVID-19; HIV; Infectious diseases; SDG 3: Good health and well-being; long COVID; post COVID condition.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:
Prevalence estimates (%) of self-reported comorbidities by PCC status among DC Cohort COVID-19 survey participants, February 28, 2022-May 3, 2023 (PCC n= 118, no PCC n=136)
Figure 2:
Figure 2:
Prevalence estimates (%) of initial COVID-19 symptoms by PCC status among DC Cohort COVID-19 survey participants, February 28, 2022-May 3, 2023 (PCC n= 118, no PCC n=136)
Figure 3:
Figure 3:
Prevalence (%) of PCC symptoms among DC Cohort COVID-19 survey participants, February 28, 2022-May 3, 2023, by sub-phenotype (PCC n=118, no PCC n=136)

References

    1. Aiyegbusi OL, Hughes SE, Turner G, Rivera SC, McMullan C, Chandan JS, Haroon S, Price G, Davies EH, Nirantharakumar K, Sapey E, & Calvert MJ (2021). Symptoms, complications and management of long COVID: a review. J R Soc Med, 114(9), 428–442. 10.1177/01410768211032850 - DOI - PMC - PubMed
    1. ATN. (2020). COVID Questionnaire Draft. Retrieved February 9, 2023 from https://clelandcm.github.io/COVID19-Interview-Items/COVID-Items.html#atn
    1. Barth SK, Saulters KJ, Balba GP, Monroe AK, Horberg MA, Kumar PN, Greenberg AE, & Castel AD (2023). Mixed Methods Analysis of Telehealth Experience, Satisfaction, and Quality of Care During the COVID Pandemic Among Persons with HIV in Washington, DC. AIDS Behav. 10.1007/s10461-023-04198-7 - DOI - PMC - PubMed
    1. Behar-Zusman V, Chavez JV & Gattamorta K (2020). Developing a Measure of the Impact of COVID-19 Social Distancing on Household Conflict and Cohesion Fam Process, Sep;59(3):1045–1059(February 9, 2023). 10.1111/famp.12579 - DOI - PMC - PubMed
    1. Carfì A, Bernabei R, & Landi F (2020). Persistent Symptoms in Patients After Acute COVID-19. JAMA, 324(6), 603–605. 10.1001/jama.2020.12603 - DOI - PMC - PubMed

LinkOut - more resources